Potency, Efficacy and Durability of DNA/DNA, DNA/Protein and Protein/Protein Based Vaccination Using gp63 Against Leishmania donovani in BALB/c Mice
2011

Long-Term Protection with gp63 Vaccination Against Leishmania donovani in Mice

Sample size: 5 publication 10 minutes Evidence: high

Author Information

Author(s): Saumyabrata Mazumder, Maji Mithun Das, Ali Nahid

Primary Institution: Indian Institute of Chemical Biology, Kolkata, India

Hypothesis

The study evaluates the potency, efficacy, and durability of different vaccination strategies against Leishmania donovani.

Conclusion

The DNA-prime/Protein-boost vaccination strategy resulted in robust immune responses and durable protection against L. donovani.

Supporting Evidence

  • Vaccination with the DNA-prime/Protein-boost approach showed significantly enhanced immune responses.
  • Long-term protection was achieved with a reduction in parasite load by 107 fold in the liver and 1010 fold in the spleen.
  • HPB vaccination induced a mixed Th1/Th2 response before infection and polarized towards Th1 after challenge.

Takeaway

Researchers tested different vaccines to see which one helps mice fight off a disease caused by a tiny bug, and found that a special combination worked best.

Methodology

The study involved immunizing BALB/c mice with various vaccine regimens and measuring immune responses and parasite loads after challenge infection.

Limitations

The study was conducted in a murine model, which may not fully replicate human responses.

Participant Demographics

BALB/c mice, 4-6 weeks old.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.pone.0014644

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication